PathMaker Neurosystems Receives FDA Breakthrough Device Designation For Use of the MyoRegulator(R) Neuromodulation Device in ALS For Slowing the Progression of Functional Symptoms
PathMaker Neurosystems Receives FDA Breakthrough Device Designation For Use of the MyoRegulator(R) Neuromodulation Device in ALS For Slowing the Progression of Functional Symptoms GlobeNewswire December 17, 2025 Boston, MA and Providence, RI, Dec. 17, 2025 (GLOBE NEWSWIRE) — PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neurotechnology company developing a breakthrough non-invasive approach for treating Amyotrophic Lateral […]